title: Chemometrics-assisted Spectrofluorimetric Determination of Two Co-administered Drugs of Major Interaction, Methotrexate and Aspirin, in Human Urine Following Acid-induced Hydrolysis.
abstract: Methotrexate (MTX) is widely used to treat rheumatoid arthritis (RA), mostly along with non-steroidal anti-inflammatory drugs (NSAIDs), the most common of which is aspirin or acetyl salicylic acid (ASA). Since NSAIDs impair MTX clearance and increase its toxicity, it was necessary to develop a simple and reliable method for the monitoring of MTX levels in urine samples, when coadministered with ASA. The method was based on the spectrofluorimetric measurement of the acid-induced hydrolysis product of MTX, 4-amino-4-deoxy-10-methylpteroic acid (AMP), along with the strongly fluorescent salicylic acid (SA), a product of acid-induced hydrolysis of aspirin and its metabolites in urine. The overlapping emission spectra were resolved using the derivative method (D method). In addition, the corresponding derivative emission spectra were convoluted using discrete Fourier functions, 8-points sin xi polynomials, (D/FF method) for better elimination of interferences. Validation of the developed methods was carried out according to the ICH guidelines. Moreover, the data obtained using derivative and convoluted derivative spectra were treated using the non-parametric Theil's method (NP), compared with the least-squares parametric regression method (LSP). The results treated with Theil's method were more accurate and precise compared with LSP since the former is less affected by the outliers. This work offers the potential of both derivative and convolution using discrete Fourier functions in addition to the effectiveness of using the NP regression analysis of data. The high sensitivity obtained by the proposed methods was promising for measuring low concentration levels of the two drugs in urine samples. These methods were efficiently used to measure the drugs in human urine samples following their co-administration.
authors.affiliation: Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi Arabia. hadirrona@yahoo.com.
authors.forename: Hadir M
authors.initials: HM
authors.lastname: Maher
authors.forename: Marwa A A
authors.initials: MA
authors.lastname: Ragab
authors.forename: Eman I
authors.initials: EI
authors.lastname: El-Kimary
mesh_terms: D001241:Aspirin / Q000494:pharmacology* / Q000652:urine; D019295:Computational Biology; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D006868:Hydrolysis; D008727:Methotrexate / Q000494:pharmacology* / Q000652:urine; D013050:Spectrometry, Fluorescence; D016482:Urinalysis / Q000379:methods*
chemical_list: D001241:Aspirin; D008727:Methotrexate